Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
19/08/2026 14:02
BRIEF-Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc Aug 19 (Reuters) - Femasys Inc FEMY.O:
FEMASYS ANNOUNCES FDA APPROVAL OF MODULAR PMA SUBMISSION APPROACH FOR FEMBLOC®
FEMASYS - FDA APPROVES MODULAR PMA PATHWAY FOR FEMBLOC IN THE UNITED STATES
FEMASYS - FEMBLOC APPROVED FOR MARKETING IN EUROPE AND SELECT INTERNATIONAL MARKETS
Source text: ID:nGNX5XnJQ8
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview